OCF001 Gel for Vaginal Yeast Infection
(BLOSSOM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Evaluating the Safety, Tolerability, and Efficacy of OCF001 Intravaginal Gel in Women with Acute Vulvovaginal Candidiasis
Who Is on the Research Team?
Christina Muzny, MD
Principal Investigator
UAB Sexual Health Research Clinic
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 5 g of OCF001 or placebo vaginal gel once daily for 7 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- OCF001 Intravaginal Gel
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Participants will receive 5 g of OCF001 vaginal gel once daily for 7 days.
Participants will receive 5 g of placebo vaginal gel once daily for 7 days
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sano Chemicals Inc
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.